Translational cancer biologist and Postdoctoral Research Fellow at Albert Einstein College of Medicine, specializing in patient-derived organoid (PDO) models for gastrointestinal cancers. Research focuses on transcriptional stress biology, CDK9-targeted therapeutics, and lineage-specific vulnerabilities in colorectal gastric cancers and biliary tract cancers. Extensive experience integrating functional drug screening, multi-omics profiling, and molecular perturbation approaches to identify therapeutic targets and biomarkers. Proven ability to lead collaborative research, mentor trainees, and translate mechanistic discoveries into preclinical therapeutic outcomes.